cs.RONov 2, 2026

Clinician-AI Collaboration in Endovascular Neurointerventions: In-Vitro User Study of Copilot Assistance Modes for Robotic Navigation Across the Autonomy Spectrum

Authors: Nikola Fischer, Harry Robertshaw, S. M. Hadi Sadati, Xingyu Chen, Weiyuan Deng, Benjamin Jackson, Michael Adofo Kwakye, Sara Sciacca, 

Organizations: School of Biomedical Engineering & Imaging Sciences, King’s College London, UK · School of Engineering and Materials Science, Queen Mary University of London, UK · Department of Neuroradiology, King’s College Hospital NHS Foundation Trust, London, UK · The Walton Centre NHS Foundation Trust, Liverpool, UK · 

Abstract

Mechanical thrombectomy (MT) is an effective treatment for acute ischemic stroke, yet access remains limited by the availability of neurointerventional expertise. Telerobotic and AI-assisted systems may help address this challenge, but it remains unclear how clinicians interact with different levels of autonomy and how autonomous navigation systems perform in realistic environments. This work introduces Copilot Assistance Modes (CAMs), a framework for clinician-AI collaboration in robotic endovascular navigation spanning the autonomy spectrum from manual operation to full autonomy. In the first in-vitro user study comparing clinician-AI collaboration strategies, 11 experts and two students evaluated six navigation modes in a patient-specific vascular phantom. Objective performance metrics were combined with subjective assessments, including workload and usability. Autonomous performance was additionally evaluated both in silico and in vitro to investigate sim-to-real transfer. Hands-on manual navigation achieved the strongest overall performance (100% success). While fully autonomous navigation achieved 81% success in simulation, performance dropped to 23% in vitro. In contrast, several clinician-AI shared-autonomy modes achieved success rates of 92-97%, approximately four times higher than full autonomy and comparable to direct robotic control (95%), demonstrating mitigation of sim-to-real domain shift through clinician-AI collaboration. Among the evaluated AI-driven approaches, user-directed task delegation and rotational shared control demonstrated the most favorable balance between performance and clinician acceptance. These findings suggest that effective clinician-AI collaboration and allocation of control authority may currently be more important for reliable robotic neurointerventional navigation than increasing autonomy alone.

Figures & tables

Explore similar work

Mar 30, 2026

A Position Statement on Endovascular Models and Effectiveness Metrics for Mechanical Thrombectomy Navigation, on behalf of the Stakeholder Taskforce for AI-assisted Robotic Thrombectomy (START)

While we are making progress in overcoming infectious diseases and cancer; one of the major medical challenges of the mid-21st century will be the rising prevalence of stroke. Large vessels occlusions are especially debilitating, yet effective treatment (needed within hours to achieve best outcomes) remains limited due to geography. One solution for improving timely access to mechanical thrombectomy in geographically diverse populations is the deployment of robotic surgical systems. Artificial intelligence (AI) assistance may enable the upskilling of operators in this emerging therapeutic delivery approach. Our aim was to establish consensus frameworks for developing and validating AI-assisted robots for thrombectomy. Objectives included standardizing effectiveness metrics and defining reference testbeds across in silico, in vitro, ex vivo, and in vivo environments. To achieve this, we convened experts in neurointervention, robotics, data science, health economics, policy, statistics, and patient advocacy. Consensus was built through an incubator day, a Delphi process, and a final Position Statement. We identified that the four essential testbed environments each had distinct validation roles. Realism requirements vary: simpler testbeds should include realistic vessel anatomy compatible with guidewire and catheter use, while standard testbeds should incorporate deformable vessels. More advanced testbeds should include blood flow, pulsatility, and disease features. There are two macro-classes of effectiveness metrics: one for in silico, in vitro, and ex vivo stages focusing on technical navigation, and another for in vivo stages, focused on clinical outcomes. Patient safety is central to this technology's development. One requisite patient safety task needed now is to correlate in vitro measurements to in vivo complications.
Apr 22, 2026

Toward Safe Autonomous Robotic Endovascular Interventions using World Models

Autonomous mechanical thrombectomy (MT) presents substantial challenges due to highly variable vascular geometries and the requirements for accurate, real-time control. While reinforcement learning (RL) has emerged as a promising paradigm for the automation of endovascular navigation, existing approaches often show limited robustness when faced with diverse patient anatomies or extended navigation horizons. In this work, we investigate a world-model-based framework for autonomous endovascular navigation built on TD-MPC2, a model-based RL method that integrates planning and learned dynamics. We evaluate a TD-MPC2 agent trained on multiple navigation tasks across hold out patient-specific vasculatures and benchmark its performance against the state-of-the-art Soft Actor-Critic (SAC) algorithm agent. Both approaches are further validated in vitro using patient-specific vascular phantoms under fluoroscopic guidance. In simulation, TD-MPC2 demonstrates a significantly higher mean success rate than SAC (58% vs. 36%, p < 0.001), and mean tip contact forces of 0.15 N, well below the proposed 1.5 N vessel rupture threshold. Mean success rates for TD-MPC2 (68%) were comparable to SAC (60%) in vitro, but TD-MPC2 achieved superior path ratios (p = 0.017) at the cost of longer procedure times (p < 0.001). Together, these results provide the first demonstration of autonomous MT navigation validated across both hold out in silico data and fluoroscopy-guided in vitro experiments, highlighting the promise of world models for safe and generalizable AI-assisted endovascular interventions.
Feb 20, 2026

Toward AI Autonomous Navigation for Mechanical Thrombectomy using Hierarchical Modular Multi-agent Reinforcement Learning (HM-MARL)

Mechanical thrombectomy (MT) is typically the optimal treatment for acute ischemic stroke involving large vessel occlusions, but access is limited due to geographic and logistical barriers. Reinforcement learning (RL) shows promise in autonomous endovascular navigation, but generalization across 'long' navigation tasks remains challenging. We propose a Hierarchical Modular Multi-Agent Reinforcement Learning (HM-MARL) framework for autonomous two-device navigation in vitro, enabling efficient and generalizable navigation. HM-MARL was developed to autonomously navigate a guide catheter and guidewire from the femoral artery to the internal carotid artery (ICA). A modular multi-agent approach was used to decompose the complex navigation task into specialized subtasks, each trained using Soft Actor-Critic RL. The framework was validated in both in silico and in vitro testbeds to assess generalization and real-world feasibility. In silico, a single-vasculature model achieved 92-100% success rates on individual anatomies, while a multi-vasculature model achieved 56-80% across multiple patient anatomies. In vitro, both HM-MARL models successfully navigated 100% of trials from the femoral artery to the right common carotid artery and 80% to the right ICA but failed on the left-side vessel superhuman challenge due to the anatomy and catheter type used in navigation. This study presents the first demonstration of in vitro autonomous navigation in MT vasculature. While HM-MARL enables generalization across anatomies, the simulation-to-real transition introduces challenges. Future work will refine RL strategies using world models and validate performance on unseen in vitro data, advancing autonomous MT towards clinical translation.